Guggenheim Capital’s Genomic Health, Inc. GHDX Stock Holding History

Guggenheim Capital’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,649	Closed	-$396K	–	2211
2019 Q1	$396K	Sell	5,649 -4,444	-44%	-$330K	﹤0.01%	1791
2018 Q4	$650K	Sell	10,093 -338	-3%	-$23.7K	0.01%	1559
2018 Q3	$732K	Buy	10,431 +19	+0.2%	+$1.11K	﹤0.01%	1773
2018 Q2	$524K	Buy	10,412 +1,968	+23%	+$78.1K	﹤0.01%	1926
2018 Q1	$264K	Buy	+8,444	New	+$280K	﹤0.01%	2559
2013 Q3	–	Sell	-72,263	Closed	-$2.29M	–	3214
2013 Q2	$2.29M	Buy	+72,263	New	+$2.37M	0.01%	1443

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital's GHDX Position: Q2 2019 in Review

Guggenheim Capital sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 5,649 shares — an estimated $396K sold.

Guggenheim Capital first reported a position in GHDX in Q2 2013 and held it in 6 quarters. The position peaked at $2.29M in Q2 2013. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

Guggenheim Capital reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
Guggenheim Capital sold 5,649 Genomic Health, Inc. shares in Q2 2019, an estimated $396K.
Guggenheim Capital first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 6 quarters.
Guggenheim Capital's Genomic Health, Inc. position peaked at $2.29M in Q2 2013.
215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Guggenheim Capital's 13F filing for Q2 2019, filed 14 Aug 2019.